Regulatory Updates
Sep 16, 2026•3 min read
FDA Approves Lannett’s VELTANE 4 mg Oral Tablet (ANDA 084088)
The FDA has granted approval for Lannett’s generic VELTANE oral tablet containing 4 mg brompheniramine maleate (ANDA 084088).
Regulatory Updates
Aug 30, 2026•3 min read
FDA Approves ANDA084351 for Brompheniramine Maleate 4 mg Tablet (Now Discontinued)
The FDA granted approval (ANDA084351) for a 4 mg oral tablet of brompheniramine maleate by IVAX Sub Teva Pharm; the product is currently listed as discontinued.